Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

RM Materials - Reference Articles for Molecular Oncology

  1. RA MacLeod, S Nagel, M Scherr, B Schneider, WG Dirks, CC Uphoff, H Quentmeier, HG Drexler (2008). Human leukemia and lymphoma cell lines as models and resources. Curr Med Chem 15(4):339-359.
     
  2. MR Gerstenblith, AM Goldstein, MA Tucker, MC Fraser (2008), Genetic testing for melanoma predisposition: current challenges. Cancer Nurs 30(6):452-459.
     
  3. J Saldanha, M Silvy, N Beaufils, R Arlinghaus, G Barbany, S Branford, JM Cayuela, G Cazzaniga, M Gonzalez, D Grimwade, V Kairisto, K Miyamura, M Lawler, T Lion, E Macintyre, FX Mahon, MC Muller, M Ostergaard, H Pfeifer, G Saglio, C Sawyers, O Spinelli, VH van der Velden, JQ Wang, K Zoi, V Patel, P Phillips, P Matejtschuk, J Gabert (2007). Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements. Leukemia 21(7):1481-1487.
     
  4. R Yao & E Schneider (2007), Detection of B- and T-cell-specific gene rearrangements in 13 cell lines and 50 clinical specimens using the BIOMED-2 and the original InVivoScribe primers. Leukemia & Lymphoma 48(4):837-840.
     
  5. RL Levine et al. (2007), Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Reviews Cancer 7:673-683.
     
  6. H Quentmeier, RA MacLeod, M Zaborski, HG Drexler (2006). JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders. Leukemia 20(3):471-476.
     
  7. O Ikediobi et al (2006), Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther 5(11):2606-2612.
     
  8. K Inokuchi (2006), Chronic Myelogenous Leukemia: from molecular biology to clinical aspects and novel targeted therapies. Nippon Med Sch 73(4):178-192.
     
  9. R Ren (2005), Mechanisms of BCR-ABL in the pathogenesis of Chronic Myelogenous Leukemia. Nat Reviews Cancer 5:172-183.
     
  10. B Messahel et al. (2005), Clinical features of molecular pathology of solid tumours in childhood. Lancet Oncol 6:421-430.
     
  11. B Chen et al. (2005), Developing a sustainable process to provide quality control materials for genetic testing. Genet Med 7(8):543-49.
     
  12. B Sunar-Reeder, DH Atha, S Aydemir, DJ Reeder, L Tully, AR Khan, CD O’Connell (2004). Use of TP53 reference materials to validate mutations in clinical tissue specimens by single-stranded conformational polymorphism analysis. Mol Diagn 8(2):123-130.
     
  13. HG Drexler, WG Dirks, Y Matsuo, RA MacLeod (2003). False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17(2):416-246.
     
  14. R Kurzrock et al. (2003), Philadelphia chromosome—positive Leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 138:819-830.
     
  15. JJM van Dongen et al. (2003), Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 17:2257-2317.
     
  16. DL Stirewalt & JP Radich (2003), The role of FLT3 in haematopoietic malignancies. Nat Reviews Cancer 3:650-665.
     
  17. R Yao, SA Rich, & E Schneider (2002), Validation of sixteen Leukemia and Lymphoma cell lines as controls for molecular gene rearrangement assays. Clin Chem 48(8):1344-1351.
     
  18. S Pelengaris, M Khan, & G Evan (2002), c-MYC: more than just a matter of life and death. Nat Reviews Cancer 2:764-776.
     
  19. HG Drexler et al. (2000), Continuous hematopoietic cell lines as model systems for Leukemia-Lymphoma research. Leukemia Res 24:881-911.
     
  20. JE Rubnitz & WM Crist (1997), Molecular genetics of childhood cancer: implications for pathogenesis, diagnosis, and treatment. Pediatrics 100:101-108.
     
 
Contact Us:
  • Centers for Disease Control and Prevention,
    Division of Laboratory Programs, Standards, and Services
    1600 Clifton Road
    Mailstop F-11
    Atlanta, GA 30333, USA
  • CLIA Direct Line:
    404-498-2290
  • CLIA@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO